In addition, co-culture experiments using F10-OVA melanoma cells and tumor-specific CD3+ T cells showed that EGCG reduced PD-L1 mRNA expression by about 30%, while also restoring interleukin-2 mRNA expression in the CD3+ T cells. Here, CD274 is linked to neoplasm.